Translational and Regenerative Immunotherapy for Spontaneous Disease in Dogs
Biobusiness Grant Recipient: Wesley Wierson, PhD
Grant Period: 2020-2021
Award Value: $100,000
Site: LifEngine Animal Health Laboratories Incorporated
Project Summary: LEAH Labs is bringing regenerative immunotherapy to dogs. We use gene editing to enable the translation of cell therapies from successful application in humans into the canine market. We aim to treat spontaneous, naturally occurring disease in dogs as a clear unmet business need, while also using dogs as a model to better inform human therapeutic intervention.